Global Rabies Treatment Market to Grow at a CAGR of 4.9% by 2017-2021: Segmentation By Application, Product Type & Route of Administration - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Rabies Treatment Market 2017-2021" report to their offering.

The global rabies treatment market to grow at a CAGR of 4.91% during the period 2017-2021.

The report, Global Rabies Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

The latest trend gaining momentum in the market is introduction of monoclonal antibodies. The spread of rabies infection can be prevented by the immediate administration of CCVs and RIGs. However, HRIG is not available developing countries such as India due to their high cost and transport complexities. Moreover, HRIG may transmit blood-borne diseases, as they are derived from human blood. Similarly, ERIG, derived from horse serum, causes various adverse effects. Extensive research and rigorous clinical trials to overcome this hurdle and meet the unmet demand for cost-effective biologics have led to the introduction of monoclonal antibodies to provide immediate immunity against rabies.

Key vendors

  • Cadila Healthcare
  • GlaxoSmithKline
  • Merial
  • Sanofi

Other prominent vendors

  • Merck
  • Pfizer

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: Understanding rabies

PART 06: Pipeline analysis

PART 07: Market landscape

PART 08: Market segmentation by application

PART 09: Market segmentation by product type

PART 10: Market segmentation by route of administration

PART 11: Geographical segmentation

PART 12: Decision framework

PART 13: Drivers and challenges

PART 14: Market trends

PART 15: Vendor landscape

PART 16: Key vendor analysis

PART 17: Appendix

For more information about this report visit http://www.researchandmarkets.com/research/zc8rcp/global_rabies

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infectious Diseases Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infectious Diseases Drugs